<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0006309" disease_type="Disease or Syndrome" abbrv="">Brucellosis</z:e> is a <z:e sem="disease" ids="C0854537" disease_type="Disease or Syndrome" abbrv="">zoonotic infection</z:e> and has endemic characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>Neurobrucellosis is an uncommon complication of this <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to present unusual clinical manifestations and to discuss the management and outcome of a series of 18 neurobrucellosis cases </plain></SENT>
<SENT sid="3" pm="."><plain>Initial clinical manifestations consist of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> in one case, white matter lesions and demyelinating syndrome in three cases, intracranial granuloma in one case, <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e> in two cases, sagittal sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> in one case, <z:e sem="disease" ids="C1710146" disease_type="Disease or Syndrome" abbrv="">spinal arachnoiditis</z:e> in one case, intracranial <z:hpo ids='HP_0002633'>vasculitis</z:hpo> in one case, in addition to <z:hpo ids='HP_0001287'>meningitis</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="4" pm="."><plain>Eleven patients were male and seven were female </plain></SENT>
<SENT sid="5" pm="."><plain>The most prevalent symptoms were <z:hpo ids='HP_0002315'>headache</z:hpo> (83%) and <z:hpo ids='HP_0001945'>fever</z:hpo> (44%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were treated with <z:chebi fb="0" ids="28077">rifampicin</z:chebi>, <z:chebi fb="1" ids="50845">doxycycline</z:chebi> plus <z:chebi fb="0" ids="45924">trimethoprim</z:chebi>-<z:chebi fb="0" ids="9332">sulfamethoxazole</z:chebi> or <z:chebi fb="0" ids="29007">ceftriaxone</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Duration of treatment (varied 3-12 months) was determined on basis of the CSF response </plain></SENT>
<SENT sid="8" pm="."><plain>In four patients presented with left mild sequelae including <z:hpo ids='HP_0002381'>aphasia</z:hpo>, hearing loss, <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, although mortality is rare in neurobrucellosis, its sequelae are significant </plain></SENT>
<SENT sid="10" pm="."><plain>In neurobrucellosis various clinical and neuroradiologic signs and symptoms can be confused with other <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>In inhabitants or visitors of endemic areas, neurobrucellosis should be kept in mind in cases that have unusual neurological manifestations </plain></SENT>
</text></document>